Literature DB >> 12877910

A genome-wide search for genes affecting circulating fibrinogen levels in the Framingham Heart Study.

Qiong Yang1, Geoffrey H Tofler, L Adrienne Cupples, Martin G Larson, DaLi Feng, Klaus Lindpaintner, Daniel Levy, Ralph B D'Agostino, Christopher J O'Donnell.   

Abstract

INTRODUCTION: Circulating levels of fibrinogen are associated with atherosclerosis and predict future coronary heart disease and stroke. Levels of fibrinogen are correlated among family members, suggesting a heritable component. Variants of the beta-fibrinogen gene subunit on 4q28 are associated with fibrinogen levels but explain only a small proportion of the total genetic variability. It remains unknown what role, if any, is played by other genetic variants in the inter-individual variability in levels of fibrinogen in the general population.
MATERIALS AND METHODS: We conducted a 10-cM spaced genome-wide scan using 402 original cohort subjects and 1193 offspring subjects from 330 extended families of the Framingham Heart Study. Heritability and linkage analyses were carried out using variance component methods. Regression analyses were performed to adjust for traditional risk factors and HindIII beta-148 genotypes. RESULTS AND DISCUSSIONS: The total heritability was estimated as 0.24. The highest and second highest LOD scores of linkage were found on chromosomes 2 (LOD=1.5 at 243 cM) and 10 (LOD=2.4 at 87 cM) using only offspring subjects in the analysis, and on chromosomes 2 (LOD=2.1 at 242 cM) and 10(LOD=1.4 at 86 cM), 17 (LOD=1.4 at 96 cM) and 20 (LOD=1.4 at 80 cM) using both original cohort and offspring. These results suggest that there may be influential genetic regions on these chromosomes. While no linkage with genome-wide significance was detected, further research to confirm our findings is warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877910     DOI: 10.1016/s0049-3848(03)00288-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  12 in total

1.  Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Gail P Jarvik; Leslie A Lange; Mary Cushman; Russell P Tracy; Alexander P Reiner
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

2.  Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

Authors:  K Ding; D Feng; M de Andrade; T H Mosley; S T Turner; E Boerwinkle; I J Kullo
Journal:  J Hum Hypertens       Date:  2007-10-25       Impact factor: 3.012

3.  Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.

Authors:  Duraid Hamid Naji; Chengcheng Tan; Fabin Han; Yuanyuan Zhao; Junhan Wang; Dan Wang; Jingjing Fa; Sisi Li; Shanshan Chen; Qiuyun Chen; Chengqi Xu; Qing K Wang
Journal:  Mol Genet Genomics       Date:  2017-09-11       Impact factor: 3.291

4.  Quantitative determination of fibrinogen of patients with coronary heart diseases through piezoelectric agglutination sensor.

Authors:  Qinghai Chen; Xing Hua; Weiling Fu; Dongbo Liu; Ming Chen; Guoru Cai
Journal:  Sensors (Basel)       Date:  2010-03-16       Impact factor: 3.576

5.  Linkage study of fibrinogen levels: the Strong Heart Family Study.

Authors:  Lyle G Best; Kari E North; Xia Li; Vittorio Palmieri; Jason G Umans; Jean MacCluer; Sandy Laston; Karin Haack; Harald Goring; Vincent P Diego; Laura Almasy; Elisa T Lee; Russell P Tracy; Shelley Cole
Journal:  BMC Med Genet       Date:  2008-08-12       Impact factor: 2.103

6.  IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Martijn A Spruit; Jeanine J Houwing-Duistermaat; Daniel Kotz; Valéria Lima Passos; Emiel F M Wouters
Journal:  BMC Med Genet       Date:  2009-03-09       Impact factor: 2.103

7.  Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.

Authors:  Qiong Yang; Sekar Kathiresan; Jing-Ping Lin; Geoffrey H Tofler; Christopher J O'Donnell
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

Review 8.  Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.

Authors:  Annelyse Duvoix; Jenny Dickens; Imran Haq; David Mannino; Bruce Miller; Ruth Tal-Singer; David A Lomas
Journal:  Thorax       Date:  2012-06-28       Impact factor: 9.139

Review 9.  Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.

Authors:  Sofie Lock-Johansson; Jørgen Vestbo; Grith Lykke Sorensen
Journal:  Respir Res       Date:  2014-11-25

10.  Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.

Authors:  Abbas Dehghan; Qiong Yang; Annette Peters; Saonli Basu; Joshua C Bis; Alicja R Rudnicka; Maryam Kavousi; Ming-Huei Chen; Jens Baumert; Gordon D O Lowe; Barbara McKnight; Weihong Tang; Moniek de Maat; Martin G Larson; Susana Eyhermendy; Wendy L McArdle; Thomas Lumley; James S Pankow; Albert Hofman; Joseph M Massaro; Fernando Rivadeneira; Melanie Kolz; Kent D Taylor; Cornelia M van Duijn; Sekar Kathiresan; Thomas Illig; Yurii S Aulchenko; Kelly A Volcik; Andrew D Johnson; Andre G Uitterlinden; Geoffrey H Tofler; Christian Gieger; Bruce M Psaty; David J Couper; Eric Boerwinkle; Wolfgang Koenig; Christopher J O'Donnell; Jacqueline C Witteman; David P Strachan; Nicholas L Smith; Aaron R Folsom
Journal:  Circ Cardiovasc Genet       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.